Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. Theratechnologies Inc. was founded in 1993 and is headquartered in Montreal, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Phone+1-514-3367800
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$52.85 million
Profitability
Miscellaneous
Employees28
OptionableNot Optionable
Theratechnologies (TSE:TH) Frequently Asked Questions
What is Theratechnologies' stock symbol?
Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."
When is Theratechnologies' next earnings date?
What price target have analysts set for TH?
2 brokerages have issued 1 year price targets for Theratechnologies' shares. Their forecasts range from C$12.00 to C$15.00. On average, they anticipate Theratechnologies' stock price to reach C$13.94 in the next twelve months. This suggests a possible upside of 67.9% from the stock's current price. View Analyst Price Targets for Theratechnologies.
What is the consensus analysts' recommendation for Theratechnologies?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Theratechnologies.
Has Theratechnologies been receiving favorable news coverage?
News headlines about TH stock have trended somewhat positive on Saturday, InfoTrie Sentiment reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Theratechnologies earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the stock's share price in the next few days.
Who are some of Theratechnologies' key competitors?
Some companies that are related to Theratechnologies include 22nd Century Group (XXII), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Actinogen Medical (ACW), Almirall (LBTSF), Altimmune (ALT), Ampio Pharmaceuticals (AMPE) and Ampliphi Biosciences (APHB).
Who are Theratechnologies' key executives?
Theratechnologies' management team includes the folowing people:
- Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
- Mr. Philippe Dubuc, Sr. VP & CFO (Age 52)
- Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
- Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)
- Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)
How do I buy shares of Theratechnologies?
Shares of TH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Theratechnologies' stock price today?
One share of TH stock can currently be purchased for approximately C$8.30.
What is Theratechnologies' official website?
How can I contact Theratechnologies?
Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The company can be reached via phone at +1-514-3367800.
MarketBeat Community Rating for Theratechnologies (TSE TH)
MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe TH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TH will underperform the S&P 500 over the long term. You may vote once every thirty days.
